Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avanafil in Generalized Erectile Dysfunction (REVIVE)
NCT00790751Phase 3Completed
- Sponsor
- VIVUS
- Start
- Nov 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of avanafil in erectile dysfunction (ED), sponsored by VIVUS. Started Nov 2008; status: completed.
02
Drugs
avanafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00790751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00790751.